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Abstract
The amphibian Xenopus laevis has the ability to regenerate axons of its optic nerve even after
metamorphosis. From previous studies done in our lab, we found that Suppressor of Cytokine
Signaling 2 (SOCS2) could be involved in the complex pathway of genes regulating nervous
system development and regeneration. 3’ and 5’ Rapid Amplification of cDNA Ends (RACE)
revealed that the 5’ untranslated region (UTR) of SOCS2 contains two splice forms. One splice
form contained a previously unidentified 68 base pair exon, which will be referred to as ‘Exon
2’, which we hypothesized is involved in post-transcriptional regulation of SOCS2. I performed
in situ hybridization on retina sections of the regenerating and non-regenerating eye 12 days after
optic nerve crush to test whether Exon 2 is specifically expressed during optic nerve
regeneration. I observed that expression of the splice form containing Exon 2 increased in the
retina. This suggests that Exon 2 does play a role in the regulation of expression of SOCS2
during regeneration. RT-PCR and qPCR were performed to study the expression differences of
the two splice forms at 3 days and 7 days after optic nerve crush. These data, when combined
with the in situ hybridization data, suggest that the 5’UTR of SOCS2 is differentially expressed
relative to the stages of regeneration. The form of the SOCS2 5’UTR that contains Exon 2 is
expressed more in the intermediate to late stages of optic nerve regeneration, whereas the form
that lacks this exon is associated with the early stages. Based on these observations, I
hypothesized that the 5’UTR with Exon 2 or without it could be functioning as an internal
ribosome entry site (IRES), to facilitate translation of SOCS2 protein under stress conditions
where cap-dependent translation is suppressed. To test this in vivo, I have created a bicistronic
fluorescent protein reporter plasmid that contains the SOCS2 5’ UTR sequences with and
without Exon 2. In vitro transcribed mRNA from two control constructs was injected into X.
laevis embryos. Assaying for expression indicated that this method can be used to determine
IRES activity. mRNA from the experimental constructs containing the SOCS2 5’UTR will be
injected into embryos for confirmation or denial of my hypothesis. From my study I hope to
better understand the regulatory mechanisms of the SOCS2 5’UTR during axon regeneration in
X. laevis.
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Introduction
The optic nerve, part of the central nervous system (CNS), connects the eye to the brain. In
anamniotes when the optic nerve is injured, it regenerates and restores the axonal connections.
The molecular mechanisms underlying this phenomenon are only partially understood. This
makes members of the anamniotes a useful group in which to study these mechanisms (Sperry,
1944). The South African claw-toed frog, Xenopus laevis has been the model organism of
choice to study optic nerve regeneration for many years (Gaze, 1959). CNS regeneration is an
area of interest because in amniotes, damage to the axons of the optic nerve is permanent. The
CNS axons of amniotes, including mammals, do not regenerate after damage. In nonregenerative axons, the portion of the injured neuron that is part of the greater cell body makes
the axon retract. The retracting region of axon is the retraction bulb, which inhibits axonal
outgrowth. A glial scar forms a physical barrier to regeneration and the local glia express growth
inhibitory compounds (Vajn et al., 2013).
In X. laevis, after sustaining damage to the optic nerve, retinal ganglion cells (RGCs) begin
generating new axons at 3 days (Zhao and Szaro, 1994). The axons grow along the periphery of
the optic tract until they reach the brain approximately 18 days after the nerve injury. The
process ends after several months, when normal vision has been restored (Szaro et al., 1985).
Previous experiments have implicated Suppressor of Cytokine Signaling 2 (SOCS2) as part of
the CNS axonal regeneration process in tadpoles (Gibbs et al., 2011).
SOCS2 is one of the eight members of the SOCS protein family (Hilton et al., 1998). Its
expression in the cell is induced by stimulation from hormones and other cytokines. SOCS2,
like the other members of the family, is able to regulate the cytokine-dependent Janus Kinase and
Signal Transducer and Activator of Transcription (JAK/STAT) signaling pathway in several
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systems in vitro (as reviewed by Rico-Bautista et al., 2006). SOCS2 is an important component
of many cell activities such as negatively regulating growth hormone signaling (Metcalf et al.,
2000) and immune responses to infection (Machado et al., 2006).
SOCS2 appears to play an important role in the development of the nervous system. In the
mouse nervous system, SOCS2 expression is high during fetal development, especially during
the process of neurogenesis and dendritic outgrowth (Polizzotto et al., 2000). Deletion of the
SOCS2 gene in mice leads to a 30-40% decrease in the density of neurons, and inducing neural
stem cells to differentiate while having SOCS2 knocked-out results in 50% fewer neurons than in
the control group. If mice neural stem cells are modified to overproduce SOCS2, more neurons
are produced (Turnley et al., 2002). SOCS2 has also been implicated in the process of ocular
dominance plasticity during development (Rietman et al., 2012). Besides influencing
neurogenesis during development, SOCS2 also has an effect on neurite outgrowth. Neural cells
that overexpress SOCS2 show more neurite extension, with increases in the amount and the
length of the neurites (Goldshmit et al., 2004).
SOCS2 also appears to play an important role in regenerative CNS axonal outgrowth in
anamniotes such as Xenopus laevis. In X. laevis, SOCS2 mRNA expression increases in the
hindbrain of the tadpole under conditions that allow regeneration of spinal cord axons, and under
conditions inhibiting axon regeneration in the spinal cord, SOCS2 mRNA levels decrease (Gibbs
et al., 2011). Preliminary experiments suggest that during optic nerve regeneration, SOCS2
protein expression increases in the retinal ganglion cell layer (RGCL) as well as other retinal
layers, and when SOCS2 is knocked down in the eye, optic nerve regeneration is markedly
reduced (unpublished data).
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To further study the role and function of SOCS2 in regeneration it is important to know the
entire sequence and the gene structure of SOCS2. Manual curation of predicted genes in the X.
laevis genome indicates that as many as 65-70% of the predicted mRNA sequences are
incomplete, with many sequences in the database missing alternatively spliced products, as well
as segments of the 5’UTR and 3’UTR. In my thesis, I describe our discovery of a 68 base pair
exon in the 5’UTR of SOCS2 that had not been previously identified and discuss the implications
of this finding for the upregulation of SOCS2 expression at the protein and mRNA levels during
optic axon regeneration.

Materials and Methods
Surgery and Total RNA Recovery
For optic nerve crush, juvenile albino Xenopus laevis frogs (<4 months post-metamorphosis)
were anesthetized [0.1% ethyl 3-aminobenzoate (MS222), Sigma-Aldrich] and the right optic
nerve was crushed at the orbit as described previously (Zhao and Szaro, 1994). All procedures
involving animals were performed in accordance with the University at Albany Institutional
Animal Care and Use Committee.
For recovery of RNA for analysis, the right, operated eye; left, unoperated eye; and brain of
each frog were collected at 3 or 7 days after optic nerve crush. Using a Polytron PT-1000, each
tissue collected was homogenized in Buffer RLT (Qiagen) or guanidine isothiocyanate (GITC)containing buffer (Ananthakrishnan and Szaro, 2008). Total RNA was extracted from
homogenate using an RNeasy Mini Kit (Qiagen) or cesium chloride ultracentrifugation as
described previously (Ananthakrishnan and Szaro, 2008).
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In situ hybridization
For analysis of mRNA expression by in situ hybridization, anesthetized frogs were dissected
and perfused with 4% paraformaldehyde and processed for cryosectioning to yield transverse
sections with a thickness of 20 μm. These sections each contained both sides of the head, as
described previously (Gervasi et al., 2003).
Digoxigenin-labeled cRNA probes were synthesized [DIG RNA labeling kit (SP6/T7),
Roche] using the plasmid generated from 5’RACE containing the SOCS2 5’UTR with the Exon
2 sequence. Probe hybridization and visualization, using alkaline phosphatase-conjugated
antibodies to digoxigenin, were performed as described previously (Gervasi et al., 2003).
Sections were imaged on a Leitz Laborlux S compound microscope using a 40X Plan
ApoChromat, 0.65NA objective and a Nikon DS-Ri1 camera.
3’Rapid Amplification of cDNA Ends
Juvenile Xenopus laevis eye oligo-d(T) selected cDNA was used as the template for a 3’
Rapid Amplification of cDNA Ends (RACE) (Frohman et al., 1988). The primers and nested
primer (Gene-Specific Primer 2) sequences are in Table 1. The 3’RACE products were cloned
into a pGEM T-Easy Vector according to the manufacturer's procedures (Promega). The
plasmids were then introduced into Subcloning Efficiency™ DH5α™ Competent Cells or MAX
Efficiency® DH5α™ Competent Cells (Invitrogen) by transformation through heat shock. The
resulting colonies were screened for those containing the insert using X-gal – IPTG induced
blue/white screening. The plasmids were purified using PureYield™ Plasmid Miniprep System
(Promega) from selected colonies following the manufacturer's procedures. The sequences of
the 3’RACE products were obtained by priming at the SP6 or T7 promoters in the plasmid
(Genewiz).
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cDNA Synthesis and 5’RACE
For 5'RACE, total RNA from Xenopus laevis stage 40 embryos was extracted using an RNeasy
Mini Kit (Qiagen). The resultant total RNA was used to synthesize the first strand of cDNA using a
gene-specific primer (Primer A) targeting specifically the SOCS2 mRNA sequence (Table 1), and
SuperScript® III Reverse Transcriptase (Invitrogen), following the manufacturer's procedures. The
reverse transcription product was then purified with Wizard® SV Gel and PCR Clean-Up System
(Promega). A poly-A tail was attached to the 3' end of the SOCS2 cDNA sequence using Terminal
Transferase (New England Biolabs).
This first strand cDNA was mixed with adaptor oligo-d(T) primer and GoTaq® Green Master
Mix (Promega) using Gene-Specific Primer B (Table 1) for a PCR reaction that would be the
first round of 5’RACE. The PCR product was used as the template for the second round of
5’RACE. The PCR product was mixed with Gene-Specific Primer C and Adaptor Primer (Table
1). The resultant cDNA was separated by agarose gel electrophoresis (Davis et al., 1994) and the
resultant DNA smears were excised, eluted, and purified using the Wizard® SV Gel and PCR
Clean-Up System (Promega), following the manufacturer's recommended procedures. This gelpurified PCR product was then cloned into pGEM T-easy vector, propagated, and sequenced as
was done for the 3'RACE products.
Preparation of plasmids for in vitro transcription of RNA for expression in Xenopus
The initial plasmid to construct the bicistronic fluorescent protein reporter was a modified
pGEM-3Z Vector (Promega) that was previously used (Lin and Szaro, 1996) in our laboratory.
This modified vector contained Green Lantern Green Fluorescent Protein (glGFP) and the rabbit
β-globin 3’UTR inserted in the HindIII site on the vector. We added an AflII restriction site after
the stop codon of glGFP and a ClaI site before the rabbit β-globin 3’UTR by performing a PCR
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with Elongase® Enzyme (Invitrogen) using appropriate primers (Table 1). The coding sequence
of the red fluorescent protein td-Tomato was amplified from pRSET-B (Life Technologies)
cloning vector to attach an AflII site at its 5’ end and a ClaI site at its 3’end.
The UTR of X. laevis SOCS2 was excised from plasmids previously made in the 5’RACE and
cloned into the glGFP/td-Tomato AflII site. IRES sequence in the pIRES2-dsRed2 (Clontech)
was also inserted into the AflII site as positive controls. Accuracy of all constructs was
confirmed by sequencing (Genewiz).
In vitro Transcription and Embryo Microinjection
Plasmids were linearized (Sal1) and transcribed in vitro (mMessage mMachine SP6 kit;
Ambion) for injection into single blastomeres of two-cell stage, periodic albino X. laevis
embryos of either sex, as described by Gervasi and Szaro (2004).
qRT-PCR
RT-PCR and qPCR was performed as described previously (Ananthakrishnan et al., 2008; Liu
and Szaro, 2011), with minor modifications. GAPDH was used as an endogenous control for
qPCR. This was performed using TaqMan Gene Expression Master Mix (Applied Biosystems),
using 1 μl of cDNA template, 250 nM TaqMan probe, and 900 nM each forward and reverse
primers (Tables 1 & 2). Data were collected using an ABI Prism 7900HT Sequence Detection
System (software version 2.3) and analyzed by the comparative C T method (Schmittgen and
Livak, 2008) Statistical comparisons between two samples were made using two-tailed Students
t tests, as indicated in text.
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Table 1. Primers
Experiment
Primer
Name
Adaptor
Gene3’RACE
Specific 1
GeneSpecific 2
Poly d(T)Adaptor
Adaptor
Gene5’RACE
Specific A
GeneSpecific B
GeneSpecific C
In situ
Exon 2
hybridization
Exon 2
qPCR
No Exon 2
pGEM3zglGFP
td-Tomato
IRES
Bicistronic
Reporter
Construct

SOCS2
5’UTR
HCV IRES
DsRed IRES

Table 2. TaqMan Probes
Probe Name
Exon 2
No Exon 2

Direction

Sequence (5’ → 3’)

Reverse
Forward

GACTCGAGTCGACATCGA
GTGGCTGGTGAAGCCACTATACA

Forward

CCGTCCTTACAGCATCTCTGTAGA

Forward

GACTCGAGTCGACATCGA(17)

Forward
Forward

GACTCGAGTCGACATCGA
TTCGATAAGATGGACAACACTGTC

Forward

GTTCCTTCTGGAGCATCTTGCAAC

Forward

GAGCTCTCCCATAGACTGAGCGAT

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

GACTAAAAAGAAGTCAATGC
TTGTGCTCTGTGGTGATACG
ACATTCAAAGATTCGCACGACTAA
TGCTCTGTGGTGATACGTTCCT
AGAGACAGGCGAGCAGATCAG
CGCTTGGCGTATCTTGGAG
GTGACAATCGATTGAGAACTTCAGGGTGAG
GTGACACTTAAGTCACTTGTACAGCTCGTC
GTGACACTTAAGATGGTGAGCAAGGGCG
GTGACAATCGATTTACTTGTACAGCTCGT
GTGACACTTAAGTTTACCAGATATGGGGAG
GTGACACTTAAGTTGACAGTGGCGTGCGC
GTGACACTTAAGGGCGACACTCCACCATAG
GTGACACTTAAGGGCGGTTTTTCTTTGAGG
ATACTTAAGGCCCCTCTCCCTCCCCCC
GTGGCGCTTAAGTGTGGCCATATTATCATC

Sequence (5’ → 3’)
6FAM-TCAATGCAGAGCTGTGGAACCTCCTCA-TAMRA
6FAM-TTCAAAGATTCGCACGGTGAACAA-TAMRA

12

Results
The SOCS2 mRNA Sequence had Incomplete 3’ and 5’UTRs
The 3’RACE using eye cDNA extended the 3’UTR of SOCS2 mRNA 508 nucleotides
downstream of the NCBI database sequence (Figure 1). The 3’UTR had the transcription
termination and polyadenylation sequence AAATAA that was lacking in the mRNA sequence
present in the database. The UTR did not have a long open reading frame. This sequence was
one result out of twenty, the other 19 sequences were identical to the current database sequence,
indicating that the poly-d(T) adaptor primer was mispriming from the string of 10 A nucleotides
at the end of the database sequence. This may explain why the 3’UTR was previously
undetected.

Figure 1. The DNA sequencing revealed a ~550 bp 3’UTR that contained a transcription
termination and polyadenylation signal. All 3’RACE sequences contained some or all of the
known SOCS2 sequence (yellow and green). One sequence contained a 505 bp extension of the
known sequence after the stop codon (un-highlighted). It also had the transcription termination
and polyadenylation signal (light blue). All sequences contained Gene-Specific Primer 2 and
Adaptor Primer (gray).
The 3’UTR sequence of SOCS2 correlates to the sequence of Scaffold 5925 from base pairs
1810221 to 1809658 on the – strand using GBrowse 7.2 (XenBase). There are no introns in the
3’UTR genome sequence, which immediately follows the coding sequence. Within the coding
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sequence, there is one intron that is 43,484 bp in length. The intron separates the first 151 bp of
the coding domain (1854314-1854164) from the remaining 458 bp (1810679-1810222).
5’RACE using Stage 40 X. laevis embryo cDNA revealed two different splice forms of the
5’UTR, one splice form containing a 68 bp exon (Figure 2B) and the other lacking this exon
(Figure 2A). Both forms of the 5’UTR were extended upstream of the NCBI database sequence.
These results were the only forms of the UTR found. None were found that exactly matched the
SOCS2 5’UTR found in the database sequence.
A

B

Figure 2. Two versions of the SOCS2 5’UTR were found in Stage 40 embryo cDNA. The
5’UTR was extended 53 bp (un-highlighted) upstream of the current database sequence (blue).
(A) One form is only extended upstream. (B) Another result had a 68 bp section (red) of the
5’UTR that did not match known SOCS2 and was within the database sequence. The known
SOCS2 5’coding domain sequence was highlighted in yellow. The Adaptor Primer and GeneSpecific Primer C are in gray. The start codon for SOCS2 (purple) was found in all sequences.
Nevertheless, both versions of the SOCS2 5’ end corresponded to sequences within a X. laevis
genome scaffold. The scaffold, Scaffold 5925, was the same one used to verify our 3’RACE
results. The first section of the 5’UTR correlated to the nucleotides 1857511-1857408. The 68
bp section of the SOCS2 5’UTR in red (Figure 2B) matched a sequence in the scaffold at
1856758-186690. There were 650 nucleotides separating these sequences in the scaffold, and
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another 2,212 bp intron separated the ~70 bp from the rest of the SOCS2 5’UTR located at
nucleotides 1854476-1854315. It was determined based on these results that the SOCS2 5’UTR
is split into three exons, with the ~70 bp exon being optional. The first 151 nucleotides of the
SOCS2 coding domain were found immediately following the 1854476-1854315 region of the
5’UTR.
The 3’ and 5’ RACE verified the sequence of SOCS2. Some corrections were made to the 3’
and 5’UTRs, but no coding domain errors were found in the NCBI database. Using Scaffold
5925, the introns and exons were mapped in Figure 3. Based on their respective order in the
SOCS2 mRNA, exons were named sequentially with Exon 2 being a cassette exon, or an exon
that could be included or excluded based upon splicing (Figure 4).

Figure 3. All SOCS2 sequences matched to sequences within Xenbase Scaffold 5925. The
scaffold determined what 3’and 5’RACE results corresponded to which exons of the SOCS2
mRNA and where in the X. laevis genome introns were located.
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Figure 4. Two splice forms of the 5’UTR of SOCS2 were found. All splice forms contained
Exons 1, 3, and 4. Exon 2 was found to be not required but sometimes included.
In situ Hybridization Correlated Expression of SOCS2 that Contains Exon 2 to Regeneration
In situ hybridization was performed on retina sections 12 days after optic nerve crush to
determine if the expression of the form of SOCS2 that includes Exon 2 plays a role in optic nerve
regeneration. This procedure revealed that the expression of Exon 2 increased during
regeneration (Figure 5B) by using antisense cRNA probes. Total SOCS2 expression detected by
an antisense probe for the coding domain in the retina increased during optic nerve regeneration
(Figure 5A), as expected from previous unpublished studies by the lab. In situ hybridization
with a sense probe from Exon 2 showed no hybridization signal in either the regenerating or nonregenerating eyes (Figure 5C).
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Figure 5. Expression of SOCS2 containing Exon 2 increases in the ganglion cell layer
(GCL) during regeneration. An antisense probe targeting Exon 2 of SOCS2 mRNA (B1, B2),
as well as one targeting the coding domain (A1, A2), show increased staining in retinal ganglion
cells of the injured eye (A2, B2) relative to those of the uninjured, contralateral eye within the
same section (A1, B1). A sense probe targeting Exon 2 of SOCS2 mRNA (C1, C2) shows no
distinct staining or differences between the two eyes.
A correlation between the elevated expression of Exon 2 form of SOCS2 and the peak of axon
outgrowth at 12 days during regeneration suggested that the two different splice forms of SOCS2
were worthy of further examination. In situ hybridization could not be used to study the splice
form that lacked Exon 2, since there is no region of the mRNA that is unique to this form.
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PCR and qPCR at 7 Days Indicated Upregulation of the Exon 2 Form of SOCS2
To study the relative expression of the two forms of SOCS2 mRNA, PCR was performed on
cDNA isolated from eye during regeneration using primers that flanked Exon 2 (Table 1). Thus,
both forms would be visible within the resultant PCR product and would migrate differently on
an agarose/TBE gel. The PCR products from the cDNAs obtained from the operated eye,
unoperated eye, and brain from X. laevis juvenile frogs 7 days after optic nerve crush can be seen
in Figure 6.
1

2

3

4

L

5

6

7

8

~200 bp
~125 bp
~75 bp

Figure 6. PCR suggested that the Exon 2 form of SOCS2 is upregulated during optic nerve
regeneration while No Exon 2 expression remains the same. The Low Molecular Weight
Ladder (New England Biolabs) was used in lane L. The No Exon 2 primers showed that the
operated eye (1), unoperated eye (2), and brain (3) lanes all shared a ~200 bp band and a ~125
bp band. GAPDH primers revealed a band at ~75 bp that was shared by the operated eye (5),
unoperated eye (6), and brain (7). No contamination was detected in the no template controls
(4,8).
The PCR data from Figure 6 using the "No Exon 2" primers showed the Exon 2 form (~200
bp) and No Exon 2 forms (~125 bp) of the SOCS2 5’UTR. The band representing the Exon 2
form in operated eye was clearly brighter than any other band at that size. The No Exon 2 form
appeared to be slightly brighter in the unoperated eye than in the operated eye, but this may be
due to primer competition between the two PCR products. GAPDH appears equivalent among
18

all the lanes (5, 6, and 7), except for the no template lane (8), which was expected. This shows
that all tissues have approximately the same abundance of GAPDH, which was used as the
endogenous gene for qPCR normalization.
qPCR of technical triplicates normalized to the average GAPDH CT value can be seen in
Appendix I Table 2. The normalized C T values for operated eye and unoperated eye were
graphed in Figure 7. The normalized CT values in unoperated versus operated eye for both the
Exon 2 and No Exon 2 forms were then tested for statistical significance within the technical
replicates using a two-tailed, homoscedastic t-test. When comparing unoperated eye and
operated eye, Exon 2 had a significance of p = 0.02 and No Exon 2 was not statistically
significant between the operated and unoperated eyes (p > 0.05).
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Figure 7. Graphical representation of normalized CT values in operated eye and
unoperated eye. The average and normalized CT value was plotted against the type of cDNA
and detector. A lower CT indicates greater expression levels of mRNA. There was a significant
difference in Exon 2 expression during optic nerve regeneration according to the Student’s t-test
performed. No Exon 2 expression levels were not significant between operated and unoperated
eyes. (* p<0.05, N.S. = not significant). Error bars indicate +/- SE, n = 3 replicates, 4 frogs per
group.
There was a difference of 2.32 cycles between the average normalized C T values for Exon 2
in operated eye vs. unoperated eye. This represents a 5.01 fold increase in expression of Exon 2
mRNA in the operated eye. These technical replicates suggest that Exon 2 increases during optic
nerve regeneration whereas the No Exon 2 form does not change its expression levels
significantly at this time during regeneration.
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PCR and qPCR at 3 Days Indicated Upregulation of the No Exon 2 Form of SOCS2
PCR products using cDNAs obtained from the operated eye, unoperated eye, and brain from
X. laevis juveniles 3 days after optic nerve crush can be seen in Figure 8.
1

2

L

3

4

~200 bp
~125 bp

Figure 8. PCR suggested that the Exon 2 form of SOCS2 is downregulated during optic
nerve regeneration while the No Exon 2 form is upregulated. The Low Molecular Weight
Ladder (New England Biolabs) was used in lane L. The No Exon 2 primers showed that the
unoperated eye (1), operated eye (2), and brain (3) lanes all shared a ~200 bp band and ~125 bp
band. No contamination was detected in the no template control (4).
The PCR data from Figure 8 using No Exon 2 primers showed the Exon 2 form (~200 bp) and
No Exon 2 forms (~125 bp) of the SOCS2 5’UTR. The band for Exon 2 is dimmer in operated
eye than in the unoperated eye and brain. The No Exon 2 form was brighter in the operated eye
when compared to unoperated eye and brain. These results were exactly the opposite of the
expression levels of the SOCS2 5’UTR splice forms seen at 7 days.
qPCR corroborated the PCR data. qPCR of technical triplicates normalized to the average
GAPDH CT value can be seen in Appendix I Table 3. The normalized CT values for operated
eye and unoperated eye were graphed in Figure 9. The normalized C T values in unoperated
versus operated for both the Exon 2 and No Exon 2 forms were then tested for statistical
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significance within the technical replicates using a two-tailed, homoscedastic t-test. When
comparing unoperated eye and operated eye, Exon 2 had a significance of p = 0.0006 and No
Exon 2 had p = 0.0003.

Figure 9. Graphical representation of normalized CT values in operated eye and
unoperated eye. There was a significant difference in Exon 2 and No Exon 2 expression during
optic nerve regeneration according to the Student’s t-test performed. (* p<0.05, N.S. = not
significant). Error bars indicate +/- SE, n = 3 replicates, 4 frogs per group.
There was a difference of 2.33 cycles between the average normalized C T values for Exon 2
in operated eye and unoperated eye. The difference between average normalized C T for No Exon
2 was 1.86 cycles. There was a 5.01 fold increase in expression of No Exon 2 mRNA and a 3.6
fold decrease in the expression of the Exon 2 form in the operated eye relative to the unoperated
eye. These data with 3 technical replicates suggest that at 3 days post optic nerve crush Exon 2
decreases during optic nerve regeneration whereas the No Exon 2 form increases in expression
levels.
22

Development of an Assay for Validation of an IRES in vivo
One possibility for the regulatory role of the SOCS2 5’UTR is that the presence or lack of
Exon 2 in the 5’UTR could be acting as an Internal Ribosome Entry Site (IRES). A common
feature of IRESes is the presence of high secondary structures. The predicted secondary
structures of the SOCS2 5’UTR using m-FOLD, an RNA structure prediction software, at 22ᵒC
with and without Exon 2 can be seen in Figure 10.
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A1

B1

A2
B2

C

Figure 10. Inclusion of Exon 2 in the 5’UTR adds a stable secondary structure not found
when Exon 2 is absent. The 5’UTR when Exon 2 is absent (A1) is similar to the 5’UTR that
includes Exon 2 (B1) except in the area of the exon junction (A2, arrow). The addition of Exon 2
(B2, red) increases the overall stability of this structure, with many bonds in the secondary
structure having the optimal energy (C).
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The predicted secondary structure of the SOCS2 5’UTR is suggestive that the UTR may be
functioning as an IRES, which can be tested by inserting the putative IRES into a bicistronic
reporter plasmid (Figure 11). Four constructs were created, differing only in the putative IRES
sequence inserted between green lantern Green Fluorescent Protein (glGFP) and td-Tomato. For
full plasmids maps for each bicistronic reporter construct, refer to Appendix II.

Figure 11. All bicistronic reporter plasmids were created with the same general sequence
and organization. A pGEM-3z (Promega) vector was manipulated to test for the presence of an
IRES. A positive control was created by inserting a commercially validated IRES (derived from
pIRES2-dsRed2). The plasmid that lacked an IRES sequence between the two fluorescent protein
coding sequences was generated and used as a negative control. The experimental plasmids
contained the complete SOCS2 5’UTR, either including or excluding Exon 2.
The control plasmids that included the pIRES2-dsRed2 IRES sequence and the no IRES insert
were linearized and in vitro transcribed into synthetic mRNAs. These mRNAs were injected into
two-cell stage X. laevis embryos. At stages 37/38 in development, the embryos were imaged for
green and red fluorescence indicating IRES activity or lack of IRES activity thereof (Figure 12).
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A2

B2
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Figure 12. Bicistronic reporter constructs were functional in X. laevis embryos. Absence of
injected mRNA (C1, C2) showed only autofluorescence of the yolk. Injection of mRNA that had
no putative IRES sequence in the AflII site resulted in expression of glGFP (B1), but no
expression of td-Tomato (B2). Injection of mRNA that contained the commercial IRES (pIRES2)
expressed both glGFP (A1) and td-Tomato (A2).
The expression of these mRNAs with the appropriate fluorescence indicated that a method
was created to test in vivo IRES activity. In Figure 12, the fluorescence of the mRNA that lacked
an IRES was dim in expression of glGFP, and will need to be replicated for a more prominent
image of fluorescence.

Discussion
I found that the mRNA sequence of SOCS2 expressed in juvenile eye and embryos was
different from that predicted from the NCBI database sequence. Using 3'RACE, I found an
extended 3’UTR with a polyadenylation and termination sequence, strongly indicating that this
longer form represents the true 3’ end. It is likely that this longer form was missed, since the
3'UTR contains a string of A's that could result in mispriming by oligo-d(T) during the reverse
transcriptase reaction. Indeed, only one of 20 clones represented the longer 3'UTR. However,
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since the other 19 lack the termination and polyadenylation signal (AAAUAA) present in the
longer form, it seems likely that this longer form represents the true 3'UTR.
The 5’UTR was revealed to be more nuanced, with two splice forms within the 5’ UTR, but
there were no changes to the coding domain. The addition of two alternatively spliced forms of
the SOCS2 5’UTR provides fresh perspectives on how SOCS2 could be regulated at the posttranscriptional level. 5'UTRs of mRNAs are often involved in translational regulation,
functioning as response elements that bind proteins and miRNAs or as alternative sites of
ribosomal entry to initiate translation internally within the mRNA instead of at the 5'-capped end.
Thus, I have hypothesized that this 68 bp exon (called ‘Exon 2’ in this paper) could be involved
in the post-transcriptional regulation of SOCS2 expression, promoting increased expression of
SOCS2 protein during the intermediate to late phases of optic nerve regeneration. Through in
situ hybridization and qPCR, the expressions of the alternatively spliced forms were correlated
with different stages of the early to intermediate phase of the regeneration process. I found that
the form lacking Exon 2 was upregulated during the earliest phase of regeneration (3 days),
while the splice form that included Exon 2 was downregulated. At the intermediate stage of
optic nerve regeneration, upregulation of expression was only seen for the form of the 5’UTR
that contained Exon 2. Thus, the two alternative splice forms were differentially expressed in the
eye at different time points during regeneration.
These changes in expression could reflect a stress or injury response at early time points
during regeneration when cap-dependent translation of many genes is suppressed. There are two
possibilities, one where Exon 2 could be forming translation inhibitory structures such as hairpin loops. The inhibitory structures could function as riboswitches or as microRNA binding
sites. These would prevent ribosomes from progressing further down the mRNA transcript into
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the coding domain. An alternative role Exon 2 could be playing is it could form secondary
structures that would regulate the internal recruitment of ribosomes to promote translation of
genes that could be required to cope with injury, when the cap dependent machinery is turned
off. This would explain why one form is preferentially expressed early in regeneration.
An internal ribosome entry site (IRES) is one such possibility as it provides an alternative
translation initiation mechanism. IRESes are sequences typically present on the 5’UTR of an
mRNA that are capable of recruiting ribosomes to initiate translation in a cap-independent
manner under the conditions of stress or injury. Since SOCS2 protein expression is regulated
during injury and cellular stress, Exon 2 could be an IRES. Structural differences, taken together
with their location in the 5'UTR, further suggest that Exon 2 may play a role in the differential
expression of SOCS2. Secondary structure predictions made using m-FOLD indicate that Exon 2
forms a stem loop structure. Such structures are a common secondary structural characteristic
found in IRESes, but there are no defining characteristics of an IRES. IRESes can be identified
only through direct experiments. One such approach is to use a bicistronic reporter assay (as
reviewed by Thompson, 2012). To test whether this might be a valid approach in Xenopus, I
made and tested a bicistronic reporter construct. I showed that a commercially available IRES
functions in Xenopus as expected, thus demonstrating the feasibility of this assay.
The data from my experiments suggest that the newly found splice forms of the SOCS2
5’UTR have distinctive roles in the regulation of SOCS2 during optic nerve regeneration. The
splice form that lacks Exon 2 is upregulated at only 3 days, an early timepoint in regeneration.
At this early stage, debris from degenerating axons is being removed by macrophages and
regeneration is just being initiated. By 7 and 12 days, expression of this form declines. During
this time, regenerating axons are working toward the optic chiasm, which they reach around 10
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days and the tectum is reached around 15 days (Ostberg and Norden, 1979). Full,
comprehensive vision is restored several months after first sustaining damage (Szaro et al.,
1985). The regenerating axons reach and cross the lesion site about 5 days after injury (Wilson
et al., 1992). Although the alternative splice form of SOCS2 that includes Exon 2 is
downregulated at 3 days, it is upregulated at 7 days and 12 days, the intermediate and late stages
of regeneration, respectively. At 7 days it is the predominant form of SOCS2 mRNA present in
the eye.
One possible explanation for these results is that during the early stages of regeneration,
SOCS2 protein expression is low due to the higher expression of the No Exon 2 form, which
lacks an IRES or other translation enhancing mechanism. At 3 days, SOCS2 protein is only
beginning to be expressed (unpublished data), and this protein may be derived primarily from the
Exon 2 containing mRNA. However, in the intermediate to late stages, the Exon 2 form of
SOCS2 increases and surpasses the No Exon 2 form, allowing for even more SOCS2 translation.
SOCS2, which peaks in protein expression at 12 days (unpublished data), could result in the
degradation of SOCS3, which is known to inhibit optic nerve regeneration in mammals (Liu et
al., 2015; Tannahill et al., 2005). In mammals, an absence of this translation enhancing
mechanism in the 5’UTR may result in the failure of rise in SOCS2 expression preventing the
process of regeneration to occur.
The unusually long (43,484 bp) sequence of the intron within the coding domain of SOCS2
was obtained from Xenbase GBrowse 7.2. Due to the length of the intron, the previous genome
sequence of X. laevis was compared using GBrowse 6.0 (XenBase), where SOCS2 is located on
Scaffold 17487. The length of the intron using this older genome sequence was 21,775 bp. Both
introns have extensive stretches of non-specified nucleotides (>9,500 bp). However, the
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presence of such a large intron within a coding domain is unlikely. It is plausible that this region
of the genome is difficult to sequence and the true length of this intron within SOCS2 has not
been elucidated. When PCR products from SOCS2 cDNA using coding domain primers are
examined with agarose/TBE, the length of the coding domain matches the database length. This
means that the two exons of SOCS2 within the genome are correct; their distance is the uncertain
aspect. Therefore the accuracy of the intron data obtained from Xenbase can only be
experimentally verified.
Less is known about the splice form that lacks Exon 2 due to no PCR or qPCR having been
performed on cDNA from frogs 12 days after optic nerve crush. This experiment will need to be
done in the future, along with biological replicates of the 7 and 3 days data. In situ hybridization
will also need to be performed in 3 and 7 days post optic nerve crush retina sections to determine
if these changes in expression of the Exon 2 form of SOCS2 are located in the retinal ganglion
cell layer, as SOCS2 expression can be seen throughout the retina (unpublished data). The
bicistronic reporter assay must be performed with the SOCS2 5’UTR with and without Exon 2 in
order to determine whether our IRES hypothesis is worth pursuing further. The control
constructs containing an IRES or no IRES are positive indications that our method is
reproducible, however we will need to reproduce our experiment to be sure. If these results are
reproducible, then I have developed an assay to detect IRES activity that can be performed in
vivo, which could arguably be more informative than an assay using cell lines. My thesis thus
lays the foundation for future studies of the role of SOCS2 in successful CNS axon regeneration.

30

References
Ananthakrishnan, L., Szaro, B.G. (2008). Transcriptional and translational dynamics of light
neurofilament subunit RNAs during Xenopus laevis optic nerve regeneration. Brain Res.
1250:27-40.
Davis, L.G., Kuehl, W.M., Battey, J.F. (1994). Basic Methods in Molecular Biology. Appleton
and Lange, Norwalk.
Frohman, M.A., Dush, M.K., Martin, G.R. (1988). Rapid production of full-length cDNAs from
rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl
Acad Scie U.S.A. 85: 8998-9002.
Gaze, R. M. (1959). Regeneration of the optic nerve in Xenopus laevis. Q J Exp Physiol Cogn
Med Sci 44: 290-308.
Gervasi, C., Thyagaraian, A., Szaro, B. G. (2003). Increased expression of multiple
neurofilament mRNAs during regeneration of vertebrate central nervous system axons. J Comp
Neurol. 461(2):262-275.
Gervasi, C., Szaro, B. G. (2004). Performing functional studies of Xenopus laevis intermediate
filament proteins through injection of macromolecules into early embryos. Methods Cell Biol.
78:673-701.
Gibbs, K. M., Chittur, S.V., Szaro B.G. (2011). Metamorphosis and the regenerative capacity of
spinal cord axons in Xenopus laevis. Eur J Neurosci 33(1): 9-25.
Goldshmit, Y., Greenhalgh, C. J., Turnley, A.M., (2004). Suppressor of cytokine signaling-2 and
epidermal growth factor regulate neurite outgrowth of cortical neurons. Eur J Neurosci 20(9):
2260-2266.
Hilton, D. J., Richardson, R. T., Alexander, W.S., Viney, E.M., Willson, T.A., Sprigg, N.S.,
Nicholson, S.A., Metcalf, D., Nicola, N.A., (1998). Twenty proteins containing a C-terminal
SOCS box form five structural classes. Proc Natl Acad Sci USA 95(1): 114-119.
Lin, W., Szaro, B. G. (1996). Effects of intermediate filament disruption on the early
development of the peripheral nervous system of Xenopus laevis. Dev Biol. 179(1):197-211.
Liu, X., Williams, P.R., He, Z. (2015). SOCS3: a common target for neuronal protection and
axon regeneration after spinal cord injury. Exp Neurol 263:364-367.
Liu, Y., Szaro, B.G. (2011). hnRNP K post-transcriptionally co-regulates multiple cytoskeletal
genes needed for axonogenesis. Dev 138(14):3079-3090.

31

Machado, F. S., Johndrow, J. E., Esper, L., Dias, A., Bafiaca, A., Serhan, C.N., Aliberti, J.
(2006). Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2
dependent. Nat Med 12(3): 330-334.
Metcalf, D., Greenhalgh, C. J., Viney, E. Willson, T. A., Starr, R., Nicola, N. A., Hilton, D. J.,
Alexander, W. S. (2000). Gigantism in mice lacking suppressor of cytokine signaling-2. Nature
405(6790):1069-1073.
Ostberg A, Norden J (1979). Ultrastructural study of degeneration and regeneration in the
amphibian tectum. Brain research 168:441–455.
Polizzotto, M. N., Bartlett, P. F., Turnley, A.M. (2000). Expression of “suppressor of cytokine
signaling” (SOCS) genes in the developing and adult mouse nervous system. J Comp Neurol
423(2): 348-358.
Rico-Bautista, E., Flores-Morales, A., Fernandez-Perez L. (2006). Suppressor of cytokine
signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 17(6): 431439.
Rietman, L. M., Sommeijer, J. P., Levelt, C. N., Heimel, J. A. (2012). Candidate genes in ocular
dominance plasticity. Front Neurosci 6:11.
Schmittgen, T.D., Livak, K.J. (2008). Analyzing real-time PCR data by the comparative C(T)
method. Nat Protoc. 3(6):1101-1108.
Sperry, R.W. (1944). Optic nerve regeneration with return of vision in anurans.. J Neurophysiol
7:351–361.
Szaro BG, Loh YP, Hunt RK (1985). Specific changes in axonally transported proteins during
regeneration of the frog (Xenopus laevis) optic nerve. J Neurosci 5:192-208.
Tannahill, G.M., Elliott, J., Barry, A.C., Hibbert, L., Cacalano, N.A., Johnston, J.A. (2005).
SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation.
Mol Cell Biol. 25(20):9115-126.
Thompson, S., (2012). So you want to know if your message has an IRES? Wiley
interdisciplinary reviews RNA 3: 697–705.
Turnley, A. M., Faux, C. H., Rietze, R.L., Coonan, J.R., Bartlett, P.F. (2002). Suppressor of
cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
Nat Neurosci 5(11):1155-1162.
Vajn, K., Plunkett, J.A., Tapanes-Castillo, A., Oudega, M. (2013). Axonal regeneration after
spinal cord injury in zebrafish and mammals: differences, similarities, translation. Neurosci bul
29:402–410.

32

Zhao, Y., Szaro, B.G. (1994). The return of phosphorylated and nonphosphorylated epitopes of
neurofilament proteins to the regenerating optic nerve of Xenopus laevis. J Comp Neurol
343:158–172.

33

APPENDIX I
Table 2. Normalized Ct Data for TaqMan qPCR at 7 Days after Optic Nerve Crush
Avg
Avg
Normalized Ct
Detector
Sample
Normalized
Normalized
Sample
Ct
St Dev
19.30
Unoperated Eye
17.08
18.23
1.12
18.32
15.83
Operated Eye
16.05
15.91
0.13
SOCS2 Exon 2
15.85
17.76
Brain
17.74
18.12
0.64
18.86
No Template
N/A
19.76
Unoperated Eye
18.32
19.07
0.72
19.12
21.10
Operated Eye
19.26
20.46
1.04
SOCS2 No Exon 2
21.01
16.48
Brain
17.24
16.92
0.39
17.04
No Template
N/A
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Table 3. Normalized Ct Data for TaqMan qPCR at 3 Days after Optic Nerve Crush
Avg
Avg
Normalized Ct
Detector
Sample
Normalized
Normalized
Sample
Ct
St Dev
16.41
Unoperated Eye
15.81
16.09
0.30
16.05
18.48
Operated Eye
18.67
18.42
0.28
SOCS2 Exon 2
18.11
18.98
Brain
21.07
3.53
19.07
25.14
No Template
44.13
15.04
Unoperated Eye
15.10
15.05
0.05
15.01
12.99
Operated Eye
13.51
13.19
0.28
SOCS2 No Exon 2
13.08
15.28
Brain
0.37
14.86
14.89
14.53
No Template
N/A
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APPENDIX II
No IRES Insert

pIRES2-DsRed2 IRES
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SOCS2 5’UTR without Exon 2

SOCS2 5’UTR with Exon 2
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